🚀 VC round data is live in beta, check it out!
Chemours Valuation Multiples
Discover revenue and EBITDA valuation multiples for Chemours and similar public comparables like Hexpol, Ashland, Ingevity, Quaker Houghton and more.
Chemours Overview
About Chemours
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Founded
2014
HQ
Employees
5.7K
Website
Sectors
Financials (LTM)
EV
$6B
Chemours Financials
Chemours reported last 12-month revenue of $6B and EBITDA of $762M.
In the same LTM period, Chemours generated $1B in gross profit, $762M in EBITDA, and $157M in net income.
Revenue (LTM)
Chemours P&L
In the most recent fiscal year, Chemours reported revenue of $6B and EBITDA of $742M.
Chemours expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | XXX | $6B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $902M | XXX | XXX | XXX |
| Gross Margin | 21% | XXX | 16% | XXX | XXX | XXX |
| EBITDA | $762M | XXX | $742M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $157M | XXX | $143M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Chemours Stock Performance
Chemours has current market cap of $3B, and enterprise value of $6B.
Market Cap Evolution
Chemours' stock price is $17.99.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $3B | 0.0% | XXX | XXX | XXX | $0.95 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChemours Valuation Multiples
Chemours trades at 1.1x EV/Revenue multiple, and 8.4x EV/EBITDA.
EV / Revenue (LTM)
Chemours Financial Valuation Multiples
As of March 17, 2026, Chemours has market cap of $3B and EV of $6B.
Equity research analysts estimate Chemours' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Chemours has a P/E ratio of 17.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 8.4x | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBIT | 15.1x | XXX | 15.9x | XXX | XXX | XXX |
| EV/Gross Profit | 5.3x | XXX | 7.1x | XXX | XXX | XXX |
| P/E | 17.2x | XXX | 18.9x | XXX | XXX | XXX |
| EV/FCF | 72.4x | XXX | 126.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Chemours Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Chemours Margins & Growth Rates
Chemours' revenue in the last 12 month grew by 4%.
Chemours' revenue per employee in the last FY averaged $1.0M.
Chemours' rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Chemours' rule of X is 22% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Chemours Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.0M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 16% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Chemours Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Hexpol | XXX | XXX | XXX | XXX | XXX | XXX |
| Ashland | XXX | XXX | XXX | XXX | XXX | XXX |
| Ingevity | XXX | XXX | XXX | XXX | XXX | XXX |
| Quaker Houghton | XXX | XXX | XXX | XXX | XXX | XXX |
| Olin | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chemours M&A Activity
Chemours acquired XXX companies to date.
Last acquisition by Chemours was on XXXXXXXX, XXXXX. Chemours acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Chemours
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialChemours Investment Activity
Chemours invested in XXX companies to date.
Chemours made its latest investment on XXXXXXXX, XXXXX. Chemours invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Chemours
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Chemours
| When was Chemours founded? | Chemours was founded in 2014. |
| Where is Chemours headquartered? | Chemours is headquartered in United States. |
| How many employees does Chemours have? | As of today, Chemours has over 5K employees. |
| Who is the CEO of Chemours? | Chemours' CEO is Denise M. Dignam. |
| Is Chemours publicly listed? | Yes, Chemours is a public company listed on NYSE. |
| What is the stock symbol of Chemours? | Chemours trades under CC ticker. |
| When did Chemours go public? | Chemours went public in 2015. |
| Who are competitors of Chemours? | Chemours main competitors are Hexpol, Ashland, Ingevity, Quaker Houghton. |
| What is the current market cap of Chemours? | Chemours' current market cap is $3B. |
| What is the current revenue of Chemours? | Chemours' last 12 months revenue is $6B. |
| What is the current revenue growth of Chemours? | Chemours revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Chemours? | Current revenue multiple of Chemours is 1.1x. |
| Is Chemours profitable? | Yes, Chemours is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Chemours? | Chemours' last 12 months EBITDA is $762M. |
| What is Chemours' EBITDA margin? | Chemours' last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Chemours? | Current EBITDA multiple of Chemours is 8.4x. |
| What is the current FCF of Chemours? | Chemours' last 12 months FCF is $89M. |
| What is Chemours' FCF margin? | Chemours' last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Chemours? | Current FCF multiple of Chemours is 72.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.